HopeStage
Back to all studies
CompletedNCT05312151

COMP360 psilocybin safety research for trauma symptoms

About this titleRead the official source — NCT05312151

Researchers studied Psilocybin, tracking side effects to assess safety and tolerability in people with PTSD.

Medication studyAges 18+United States + United Kingdom
The study in practice

Understand this study

What did researchers investigate?

Researchers studied Psilocybin, tracking side effects to assess safety and tolerability in people with PTSD.

Who was this study for?

This study was for people with PTSD. Listed age limits: from 18 years. Other eligibility criteria applied.

Listed locations
Rockville and 2 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 10, 2022
Recruitment status
Completed
Enrollment listed in the registry
22
Sponsor
COMPASS Pathways
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, United Kingdom
Age range
Over 18 Years
Official registry ID
NCT05312151
Official title
Show the full official title

The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Rockville, United States · New York, United States · London, United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers studied Psilocybin, tracking side effects to assess safety and tolerability in people with PTSD.

Who is behind this study?

The study sponsor is COMPASS Pathways.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin.

Who was this study for?

This study was for people with PTSD. Listed age limits: from 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies